These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9199199)
1. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. Wang H; Toida T; Kim YS; Capila I; Hileman RE; Bernfield M; Linhardt RJ Biochem Biophys Res Commun; 1997 Jun; 235(2):369-73. PubMed ID: 9199199 [TBL] [Abstract][Full Text] [Related]
2. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Fromm JR; Hileman RE; Weiler JM; Linhardt RJ Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372 [TBL] [Abstract][Full Text] [Related]
3. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution. Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479 [TBL] [Abstract][Full Text] [Related]
4. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity. Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058 [TBL] [Abstract][Full Text] [Related]
5. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499 [TBL] [Abstract][Full Text] [Related]
6. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Westergren-Thorsson G; Persson S; Isaksson A; Onnervik PO; Malmström A; Fransson LA Exp Cell Res; 1993 May; 206(1):93-9. PubMed ID: 7683278 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311 [TBL] [Abstract][Full Text] [Related]
8. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro. Mueller SN; Thomas KA; Di Salvo J; Levine EM J Cell Physiol; 1989 Sep; 140(3):439-48. PubMed ID: 2777882 [TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor binds to heparan sulfate in the extracellular matrix of rat growth plate chondrocytes. Chintala SK; Miller RR; McDevitt CA Arch Biochem Biophys; 1994 Apr; 310(1):180-6. PubMed ID: 8161203 [TBL] [Abstract][Full Text] [Related]
10. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Hallak LK; Collins PL; Knudson W; Peeples ME Virology; 2000 Jun; 271(2):264-75. PubMed ID: 10860881 [TBL] [Abstract][Full Text] [Related]
11. An enzyme-linked immunosorbent assay using biotinylated heparan sulfate to evaluate the interactions of heparin-like molecules and basic fibroblast growth factor. Foxall C; Holme KR; Liang W; Wei Z Anal Biochem; 1995 Nov; 231(2):366-73. PubMed ID: 8594987 [TBL] [Abstract][Full Text] [Related]
12. Capillary electrophoresis and enzyme solid phase assay for examining the purity of a synthetic heparin proteoglycan-like conjugate and identifying binding to basic fibroblast growth factor. Dimitrellos V; Lamari FN; Militsopoulou M; Kanakis I; Karamanos NK Biomed Chromatogr; 2003 Jan; 17(1):42-7. PubMed ID: 12583005 [TBL] [Abstract][Full Text] [Related]
13. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis. Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356 [TBL] [Abstract][Full Text] [Related]
14. Differential scanning fluorimetry measurement of protein stability changes upon binding to glycosaminoglycans: a screening test for binding specificity. Uniewicz KA; Ori A; Xu R; Ahmed Y; Wilkinson MC; Fernig DG; Yates EA Anal Chem; 2010 May; 82(9):3796-802. PubMed ID: 20353159 [TBL] [Abstract][Full Text] [Related]
15. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Alberdi E; Hyde CC; Becerra SP Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954 [TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms for the regulation of growth factor binding by heparin. Forsten KE; Fannon M; Nugent MA J Theor Biol; 2000 Jul; 205(2):215-30. PubMed ID: 10873433 [TBL] [Abstract][Full Text] [Related]
17. Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Théoleyre S; Kwan Tat S; Vusio P; Blanchard F; Gallagher J; Ricard-Blum S; Fortun Y; Padrines M; Rédini F; Heymann D Biochem Biophys Res Commun; 2006 Aug; 347(2):460-7. PubMed ID: 16828054 [TBL] [Abstract][Full Text] [Related]
18. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis. Hausser H; Kresse H Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870 [TBL] [Abstract][Full Text] [Related]
19. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Cai S; Liu Y; Zheng Shu X; Prestwich GD Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243 [TBL] [Abstract][Full Text] [Related]
20. Chemical sulfonation and anticoagulant activity of acharan sulfate. Wu SJ; Chun MW; Shin KH; Toida T; Park Y; Linhardt RJ; Kim YS Thromb Res; 1998 Dec; 92(6):273-81. PubMed ID: 9870894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]